Curriculum Vitae

CV Last Updated 2/9/2022



EDUCATION 


University of California Los Angeles, Los Angeles, CA 

B.S., 2007, Physiological Science


Rosalind Franklin University, North Chicago, IL

M.S., 2012, Biomedical Sciences with Certificate in Healthcare Administration


Chicago Medical School, North Chicago, IL

M.D., 2016



POSTGRADUATE TRAINING


Harbor-UCLA Medical Center

General Psychiatry Residency, 2016-2020

Chief Resident, 2019-2020


USC Institute of Psychiatry, Law, and Behavioral Science
Fellowship in Forensic Psychiatry, 2020-2021



PROFESSIONAL LICENSES AND BOARD CERTIFICATION


Board Certification in Psychiatry, Certificate #76913, issued in 9/2020

American Board of Psychiatry and Neurology, Inc.


Board Certification in Forensic Psychiatry, Certificate #2557, issued in 11/2021

American Board of Psychiatry and Neurology, Inc.


California Medical License: A150261, issued 7/2017, exp 12/2022

Medical Board of California


DEA License with X-Waiver for Suboxone

Substance Abuse and Mental Health Services Administration



HONORS AND AWARDS


Top 15% at Chicago Medical School, 2016

Psychiatry Clerkship Award, 2016



WORK EXPERIENCE


UCLA Division of Hematology-Oncology

Staff Research Associate II

2007-2012

Head and Neck Cancer Research



LEADERSHIP EXPERIENCE


Residency Selection Committee, Department of Psychiatry, Harbor-UCLA, 2016-2020

Curriculum Committee, Department of Psychiatry, Harbor-UCLA, 2019-2020

Chief Resident, Adult Outpatient Psychiatry, Harbor-UCLA, 2019-2020



TEACHING ROLES


Clinical Instructor, Department of Psychiatry, Keck School of Medicine, 2020-2021


MEMBERSHIP IN SOCIETIES


American Psychiatric Association, 2015-present

Southern California Psychiatric Society, 2016-present

American Academy of Psychiatry and the Law, 2019-present



PUBLICATIONS


1.    Ather, F., Habibi, H., Fejzo, MS., Letrent,, S., Finn, RS., Kabbinavar, F., Head, C., Wong, SG. Dacomitinib, an irreversible Pan-ErbB Inhibitor Significantly Abrogates Growth in Head and Neck Cancer Models that Exhibit Low Response to Cetuximab. PMID: 23405260. PLoS One. Epub 2013 Feb 6.



PRESENTATIONS


1. Impact of the COVID-19 Pandemic on Mental Health. Presented at Los Angeles County Superior     Court Mental Health Hearing Referees Meeting, Los Angeles, CA, 2/11/2021.


2. Personality Disorders in Primary Care. Presented at Harbor-UCLA Family Medicine Grand     Rounds, Los Angeles, CA, 1/21/2020.


3.    Investigation of Four PI3K/AKT/mTOR Small Molecule Inhibitors Demonstrates Heterogeneous Response in a Panel of 30 Head and Neck Squamous Cell Carcinoma Cell Lines. UCLA Department of Medicine Research Symposium 2010.


4.    Investigation of Signaling Pathways and Molecular Characteristics of Head and Neck Squamous Cell Carcinoma Cell Lines Demonstrates Response to HER/EGFR Directed Therapy Acts Primarily Through the MAPK Pathway and G0/G1 Cell Cycle Arrest. UCLA Department of Medicine Research Symposium 2009.


5.    Effects of Pomegranate Extract Urolithin-A on Cancer Cell Growth. UCLA Medical Student Research Conference 2007.


Popular Posts